They never tell you that the glamorous life of a PI includes hot gluing the lid of your LN2 tank back together to save $400 on a cheap piece of plastic and styrofoam.

Super excited to share our latest work with @MarcelaMaus , out this week in @Nature. We show that in vivo CRISPR screens can identify genes that enhance the efficacy of CAR T cell therapy. Brief explainer below! @MGBResearchNews @broadinstitute https://t.co/rUM3TAjkPu

🚨 New Target for cSCC Immunotherapy! 🚨 Immune checkpoint VISTA, linked to strong T cell activation in cutaneous SCC @theJIDJournal #CancerResearch #Immunotherapy #VISTA #cSCC #immunecheckpoint #Oncology #skincancer #dermatology @YaleCancer @yalederm https://t.co/z48CnuB3Co

Monday Friday

It’s time to legalize supersonic flight and Make America Boom Again 🇺🇸 You can just do things. But to do some things you have to be @POTUS

Congrats to my PhD student Omar Budayr on his 1st author review titled: Harnessing extracellular vesicle-mediated crosstalk between T cells and cancer cells for therapeutic applications Use this link for 50 days of free access to the article: https://t.co/hetu88r8P1

.@OncLive named Ethan Basch (@EthanBasch1), MD, MSc, FASCO, as one of the 2024 Giants of Cancer Care for his pioneering research in the field of patient-reported outcomes.

When you had planned to work on a grant tonight, but instead drive into lab to empty your alarming -80C freezer. #YoungPILife

Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens https://t.co/4UVmPI1uXP

Celebrating the career of Shelley Earp @UNC_Lineberger at a recent joint retreat between our Molecular Therapeutics and Clinical Research programs. Shelley has been a beloved and incredibly effective Director of our cancer center for over 20 years. 🩵

Always fun to see great science from great labs (and great friends). @DebattamaSen

Excited to share our latest work on engineered probiotic yeast to treat colitis led by Mairead Heavey! Check it out here: https://t.co/rSUVxn7tP7 @UNC_Health_Care news story here: https://t.co/cV23vD2QPc

We'd like to give a shout-out to Alex Bastian, PhD, Postdoctoral Scholar @UNC_Lineberger. Dr. Bastian was nominated for how well he brings a teaching approach to the lab.

Today, Boom announced the successful flight of XB-1, the world's first independently developed supersonic jet, at the Mojave Air & Space Port in Mojave, California. Flown by Chief Test Pilot Bill "Doc" Shoemaker, XB-1's inaugural flight marks a major milestone toward the return

A real joy spending time with a good friend and mentor during his visit to @UNC_Lineberger. Pretty impressive what they're building over at @ArsenalBio. You're welcome back anytime, @nickhaining, and I promise the crowd will serenade you again before your talk.

.@theNCI awarded a $3.2 million grant to Jen Jen Yeh (@YehlabUNC), MD, and Gary Johnson, PhD to support the first metastatic pancreatic cancer trial to evaluate whether treatment by tumor subtype will help match to more effective therapies. @UNCPancreas

Exciting opportunity to join the @WilliamKimMD Lab as a Research Technician! I highly recommend joining this collaborative lab to study bladder and kidney cancer using innovative techniques. More information in the flyer below 👇! @UNC_Lineberger @UNCurology @UNCUroOnc

Excited to share our paper in @NatImmunol describing X-CHIME, a CRISPR-based system for knocking out genes in immune cells constitutively, inducibly, sequentially, and lineage-specifically.

The Patient-Centered Outcomes Research Institute (@PCORI) has awarded Ethan Basch (@EthanBasch1), MD, MSc, FASCO, $3 million in research funding to support an initiative to implement electronic patient-reported outcomes, or ePRO, in oncology practices.

New paper: Most approved drug combinations for advanced cancer (1995-2020) have predictable clinical efficacy, because they have additive effect on Progression-Free Survival times. In @NatureCancer at https://t.co/Z7xabVpouT by @HaeunHwangbo @SC_Patterson @PlanaDeborah 1/6